Thus, it could be suggested that L-Arg or NCG supplementation attenuated the IUGR-induced hepatic cell apoptosis through promoting Bcl-2 expression as well as the Fas-dependent pathway. The gene discussed is BCL2; the disease is fetal growth restriction.